ACE and acute kidney injury: <h4>Background</h4>Discontinuation of angiotensin converting enzyme inhibitors and angiotensin receptor blockers (ACEI/ARBs) is a common component of many nephrotoxin-associated acute kidney injury (NA-AKI) prevention strategies, though their intrinsic nephrotoxic potential has been increasingly challenged.